latest news releases from the newsroom
Encysive Pharmaceuticals Inc.
Encysive Pharmaceuticals Launches Thelin (sitaxentan sodium) in Italy
HOUSTON, Nov. 26, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Italy for the treatment of pulmonary arterial hypertension (PAH). Encysive received European Union (EU) marketing authorization for THELIN from the European Commission in August 2006. THELIN is the first selective endothelin A receptor antagonist, and the first once-daily oral treatment available for patients with PAH.
Lundin Petroleum AB
Thistle Incident, UK North Sea
“Petrofac, as duty holder of the Thistle Alpha installation on behalf of Lundin
Britain Limited, can confirm that at 08.07 today a fire was detected in the
Emergency procedures were implemented and all personnel called to muster
stations. The fire was confirmed extinguished at 10:45 (GMT) and all 159
personnel on board are safe and well.
As a precautionary measure non essential personnel are being down-manned to the
nearby Murchison and Dunlin platforms. All relevant author
Lundin Petroleum AB
Thistle incident - further information
53 of the 116 non essential personnel who were down manned to the Murchison and
Dunlin platforms are now returning to the Thistle Alpha platform. 63 will
remain on the Murchison platform overnight. The current plan is to return the
remaining staff to the Thistle platform tomorrow. All personnel are safe and
There were originally 159 personnel on the Thistle Alpha platform and 43
personnel remained on the platform throughout. A fire was reported on the
platform at 08.07 today in the turb
Kahn Swick & Foti, LLC
Investor Alert: KGS Urges Investors Who Have Lost More Than $100,000 in WellCare Health Plans, Inc. to Inquire About Lead Plaintiff Position in Securities Fraud Class Action Lawsuit -- WCG
NEW ORLEANS, Nov. 24, 2007 (PRIME NEWSWIRE) -- Kahn Gauthier Swick, LLC ("KGS"), the law firm that has filed a securities fraud class action lawsuit against WellCare Health Plans, Inc. ("WellCare" or the "Company") (NYSE:WCG) on behalf of shareholders who purchased the common stock of the Company between May 8, 2006 and October 24, 2007, inclusive (the "Class Period"), urges investors who have lost more than $100,000 to inquire about applying for the lead plaintiff position in the case.